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Abstract
Background: Wnt3a regulates a canonical signaling pathway in early development that controls
the nuclear accumulation of β-catenin and its activation of Lef/Tcf-sensitive transcription of
developmentally important genes.
Results: Using totipotent mouse F9 teratocarcinoma cells expressing Frizzled-1 and biochemical
analyses, we detail the influence of Wnt3a stimulation on the expression, complexation, and
subcellular trafficking of key signaling elements of the canonical pathway, i.e., Dishevelled-2, Axin,
glycogen synthase kinase-3β, and β-catenin. Cellular content of β-catenin and Axin, and phospho-
glycogen synthase kinase-3β, but not Dishevelled-2, increases in response to Wnt3a. Subcellular
localization of Axin in the absence of Wnt3a is symmetric, found evenly distributed among plasma
membrane-, cytosol-, and nuclear-enriched fractions. Dishevelled-2, in contrast, is found
predominately in the cytosol, whereas β-catenin is localized to the plasma membrane-enriched
fraction. Wnt3a stimulates trafficking of Dishevelled-2, Axin, and glycogen synthase kinase-3β
initially to the plasma membrane, later to the nucleus. Bioluminescence resonance energy transfer
measurements reveal that complexes of Axin with Dishevelled-2, with glycogen synthase kinase-
3β, and with β-catenin are demonstrable and they remain relatively stable in response to Wnt3a
stimulation, although trafficking has occurred. Mammalian Dishevelled-1 and Dishevelled-2 display
similar patterns of trafficking in response to Wnt3a, whereas that of Dishevelled-3 differs from the
other two.
Conclusion: This study provides a detailed biochemical analysis of signaling elements key to
Wnt3a regulation of the canonical pathway. We quantify, for the first time, the Wnt-dependent
regulation of cellular abundance and intracellular trafficking of these signaling molecules. In contrast,
we observe little effect of Wnt3a stimulation on the level of protein-protein interactions among
these constituents of Axin-based complexes themselves.
Background
Wnt proteins are secreted, glycosylated and palmitoylated
ligands that bind to members of the Frizzled (Fz) family
of G protein-coupled receptors and direct aspects of early
development [1-9]. Defects in Wnt signaling are impli-
cated in numerous human diseases, e.g., cancer [10] and
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osteoporosis [11]. Upon binding of Wnt to Frizzled-1 and
its co-receptor LRP5/6, a signal is transduced ultimately to
the cytoplasmic phosphoprotein, Dishevelled (Dsh/Dvl)
[12]. Fly Dsh and the three isoforms of Dvls found in
mammals (Dvl1-3) all share three prominent, highly con-
served domains: a Dsh homology domain called DIX; a
conserved sequence element with homology to the posts-
ynaptic density protein PSD-95,  Disc-large, and ZO-1,
termed PDZ; and Disheveled, Egl-10, Pleckstrin domain,
termed DEP [13]. At the level of Dsh/Dvl, signals branch
to at least three distinct pathways, namely canonical, non-
canonical, and planar cell polarity (PCP) [14].
The canonical Wnt/β-catenin pathway stimulates stabili-
zation and accumulation of cytosolic, and then later of
nuclear β-catenin, which binds to Lef/Tcf-sensitive tran-
scription factors and activates genes necessary for early
development [15]. In the fly as in the mouse, Wnt3a binds
Frizzled-1 (Fz1) and co-receptor LRP5/6, activates Dsh/
Dvl which, in turn, suppresses the activity of a key protein
kinase, glycogen synthase kinase-3β (GSK3β) [9]. β-cat-
enin, Dishevelleds, and GSK3β a p p e a r  t o  i n t e r a c t  i n  a
multiprotein Axin based complex which includes the
product of the adenomatous polyposis coli (APC) tumor sup-
pressor gene [16,17]. Dvl is required for Wnt-dependent
inhibition of this complex. Wnt stimulates changes in the
abundance as well as the nucleo-cytoplasmic shuttling of
β-catenin and perhaps other key signaling elements in the
canonical pathway [18,19]. In the absence of biochemical
quantification, however, it is not clear whether changes in
nucleo-cytoplasmic shuttling observed by confocal micro-
scopy involve 50% or 5% of the cellular complement of
these signaling elements, information critical to a full
understanding Wnt action at the biochemical level. Devel-
oping a quantified measurement of the abundance, local-
ization, and complexation of key elements in response to
Wnt thus is an essential goal.
In the current study, we set out to ascertain the answers to
three interrelated, unresolved questions: what is the quan-
tified cellular distribution of key elements Axin, Dvl2,
GSK3β, and β-catenin in mammalian cells?; how does
stimulation by Wnt3a alter their relative abundance and
trafficking?; and, are these key protein complexes dynamic
and subject to change in response to stimulation by Wnt?
Addressing these central questions required use of classi-
cal techniques of subcellular fractionation and protein
quantification as well as bioluminescence resonance
energy transfer (BRET) measurements between protein
partners. Our study provides quantification of the relative
abundance, trafficking, and complexation of several key
signaling elements, exploiting totipotent mouse F9 terato-
carcinoma cells expressing Frizzled-1 that form primitive
endoderm in response to stimulation with Wnt3a.
Results
Wnt3a stimulates changes in cellular abundance of several 
key signaling molecules in the canonical Wnt/β-catenin 
pathway
The mouse F9 teratocarcinoma (F9) cells are embryonal
and totipotent cells that can be stimulated to form primi-
tive endoderm [6]. Wild-type F9 cells, essentially lacking
Rfz1 mRNA, are resistant to the effects of purified Wnt3a
and provide an ideal system in which to express Frizzled-
1 to study Wnt3a signaling. F9 cells were transfected with
an expression vector harboring rat Frizzled-1 (Rfz1) [6].
These Rfz1-expressing F9 cells were adopted as a model
system with which to probe biochemical features of the
influence of Wnt3a on the abundance, localization, and
complexation of key signaling elements of the canonical
Wnt/β-catenin pathway.
Treating the F9 cells with purified Wnt3a stimulates the
formation of primitive endoderm (fig. 1A). Primitive
endoderm formation was observed within 3–6 days of
treatment with Wnt3a, established by immunoblotting of
the PE-specific marker, cytokeratin Endo-A. Staining of
blots of whole-cell lysates of Wnt3a-stimulated F9 cells
with the TROMA-1 monoclonal antibody to Endo-A
reveals increased expression of Endo-A. Wnt3a provokes a
4-fold increase in the expression of the PE-marker. Activa-
tion of Lef/Tcf-sensitive transcription by β-catenin pro-
vides an earlier and robust read-out of the Wnt-stimulated
canonical pathway [10]. We analyzed the activity of a Lef/
Tcf-sensitive reporter gene, the M50 construct, which har-
bors multiple β-catenin binding sites in its promoter (fig.
1B). At 8 hr post stimulation with Wnt3a, a robust activa-
tion (~80 fold) of the M50 reporter gene was obvious. The
activity of the control gene reporter M51, which lacks the
β-catenin binding sites [20], was unaffected by treatment
with Wnt3a. Activation of Lef/Tcf-sensitive transcription
of F9 cells in response to Wnt3a could be detected as early
as 4 hr; Wnt5a, in contrast, did not activate Lef/Tcf-sensi-
tive transcription (results not shown).
We intentionally focused our analysis on several key ele-
ments of the Wnt canonical pathway, namely Axin, Dvl2,
β-catenin, and GSK3β (both native and phospho-forms),
whose trafficking has been reported to be regulated by the
Wnt canonical pathway [21]. Confocal microscopy
reveals changes in apparent localization of these signaling
elements, but cannot provide quantitative information.
Analysis of trafficking in the absence of detailed cellular
quantification of the protein (especially if its abundance
is influenced by Wnt stimulation) requires a more
detailed analysis of protein abundance as well as subcel-
lular locale. To accomplish this task, we first needed to
establish the cellular abundance for each of the signaling
elements in whole-cell lysates (fig. 1C). F9 cell lysates
were subjected to SDS-PAGE analysis and the resolvedJournal of Molecular Signaling 2007, 2:11 http://www.jmolecularsignaling.com/content/2/1/11
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proteins to immunoblotting. The blots were stained with
antibodies against Axin, β-catenin, Dvl2, GSK3β (phos-
pho- and dephospho-forms), the phosphoprotein phos-
phatase 2A (i.e., the conserved catalytic or "C"-subunit) as
well as for GAPDH (as a protein loading control). The F9
cells were either untreated (time = 0) or treated with puri-
fied Wnt3a for 5 to 90 min and then subjected to disrup-
tion, SDS-PAGE, and quantification of cellular protein
Wnt3a stimulates changes in cellular content of Wnt/β-catenin pathway signaling components Figure 1
Wnt3a stimulates changes in cellular content of Wnt/β-catenin pathway signaling components. Panel A, formation of PE was assayed 
in F9 cells expressing Rfz1 and stimulated without or with purified Wnt3a for 3 days. PE formation was assayed by measuring of expression of PE-
marker, cytokeratin endo A, using immunoblotting and staining with TROMA-1 antibody. The results shown are mean values ± S.E. from 3 inde-
pendent experiments. A representative immunoblot is shown and the mean values of the quantification displayed in the graph. Panel B, activation 
of Lcf/Tcf-sensitive transcription was assayed in F9 cells co-transfected for one-day with Rfz1 and Super8xTOPFlash (M50) or Super8xFOPFlash 
(M51) and then stimulated without and with purified Wnt3a for 8 hr. The luciferase gene reporter was assayed and is displayed relative to the 
unstimulated cells (set to 1). The results shown are mean values ± S.E. from 5 independent experiments. Panel C, cellular abundance of Axin, Dvl2, 
GSK3β, p-GSK3β, PP2A C, and β-catenin was assayed in F9 cells expressing Rfz1 and stimulated with Wnt3a for 0 to 90 min. Cells were har-
vested and lysed in a lysis buffer [50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 2 mM Na3VO4, 50 mM NaF, 1 % Triton X-100, 1 mM 
phenymethysulfonyfluoride (PMSF), 10 μg/ml leupeptin, and 10 μg/ml aprotinin]. Protein expression was established by SDS-PAGE, immunoblot-
ting, and densitometric scans of the immune complexes. A representative blot is shown and the quantification of results is shown as mean values 
± S.E. from 4 independent experiments.
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(via immunoblotting), setting the abundance of each pro-
tein established at zero time as "1" (fig. 1C).
Axin and β-catenin display Wnt3a-induced accumulation
over the 90 min stimulation (fig. 1C). At 60–90 min post
stimulation by Wnt3a, the abundance of β-catenin is
increased 3-fold, the abundance of Axin is increased 4- to
5-fold. The abundance of the phospho-GSK3β also
increases, but much more modestly (~50%), in response
to Wnt3a stimulation. The abundance of Dvl2, total
GSK3β, the protein phosphatase-2A (PP2A), and the load-
ing control GAPDH, in contrast, were essentially unaf-
fected by treating the cells with Wnt3a for periods up to 90
min.
Biochemical characterization of subcellular fractions
Results from the analysis of the cellular complement of
the signaling elements by immunoblotting clearly dem-
onstrates the need for subcellular fractionation and char-
acterization of the abundance of each of the proteins, in
advance of determinations of apparent "protein shut-
tling" in response to Wnt. Subcellular fractionation of F9
cells was performed by standard protocols and the frac-
tions characterized biochemically for enrichment in
marker proteins. Nuclei (NU), plasma membrane (PM),
and cytosol (CY, see Methods) subcellular fractions were
prepared and characterized for their enrichment by
immunoblotting and by staining of samples of fractions
with antibodies to marker proteins: Na+-K+-ATPase for
plasma membrane; glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) for cytoplasm; and the nucleolar-spe-
cific protein fibrillarin for nuclei (fig. 2A). The results
from the immunoblotting testify to the enriched character
of each subcellular fraction prepared from these cells (fig.
2A, B). Each fraction was highly enriched in the appropri-
Cellular distribution of Wnt/β-catenin signaling elements Figure 2
Cellular distribution of Wnt/β-catenin signaling elements. Large-scale cultures of mouse F9 cells expressing Rfz1 were harvested and the 
cells disrupted. Subcellular fractions were prepared from the cell masses and the fractions probed for enrichment in plasma membrane (PM), 
cytoplasm (CY), and nuclei (NU) as described in detail in the Methods. Samples of the whole-cell homogenate were subjected to subcellular frac-
tionation and their complements of cellular proteins to SDS-PAGE. Panel A, the distribution of well-known marker proteins for subcellular frac-
tions (i.e., Na+-K+-ATPase as a marker for plasma membrane, GAPDH as a marker for cytoplasm, and fibrillarin as a marker for nuclei) also was 
analyzed in each fraction to establish purity/enrichment of markers in these fractions. Panel B, resolved proteins were analyzed by immunoblot-
ting, stained with one of the following antibodies: anti-Axin, anti-β-catenin, anti-Dvl2, anti-GSK 3β, anti-p-Ser (9)-GSK 3β, and anti-PP2A C-subu-
nit. The relative amounts of the proteins distributed in each subcellular fraction was established densitometrically, based upon their distribution 
(%), the total protein content of the homogenate and fractions, and quantified analysis of blots from SDS-PAGE. The results are shown as mean 
values ± S.E. from 8-10 independent experiments.
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ate marker for the subcellular source and relatively devoid
of marker proteins for the other subcellular fractions.
To complete the biochemical characterization, the distri-
bution of cellular protein among the subcellular fractions
prepared from mouse F9 cells was determined (Table 1).
Nearly 50% of cellular protein is found in the cytosolic
fraction. As commonly observed for subcellular fractiona-
tions of other mammalian cells [22], the plasma mem-
brane-enriched fraction displayed ~30% and nuclear-
enriched fraction 12–13% of the cellular protein. The sum
of mitochondria-enriched fraction and of high-speed,
supernatant "microsomal" fraction, together representing
~10% of the cellular protein and essentially devoid of
markers for plasma membrane, cytoplasm, or nucleus,
were not further probed in these studies. The amount of
the marker proteins and signaling elements established
empirically in the plasma membrane + cytoplasm + mito-
chondria + microsomes + nuclear-enriched fractions was
set to 100% for all derivative calculations of signaling ele-
ment distribution (Table 1).
Cellular distribution of Wnt/β-catenin pathway signaling 
elements
Determination of "specific activity" (relative content of
target molecule/mg protein of sample, fig. 2), cellular pro-
tein content (Table 1), and fraction volumes (Methods),
enabled us to establish the level of relative abundance and
subcellular localization of Axin, β-catenin, Dvl2, GSK3β
and PP2A in mouse F9 cells (fig. 2B). To optimize the data
acquisition, densitometric analyses were performed on a
UMax 1000 absorbance scanner equipped with Silver-
FastAi software and quantified using Aida software. Distri-
butions of proteins were calculated based on the protein
concentration, fraction volume, and quantification of
blots under conditions in which ~95 % of marker proteins
for plasma membrane, cytosol, and nucleus are each
found in the appropriate subcellular fraction. The data are
the results of more than nine large-scale preparations of
F9 cells, each assayed on independent occasions. This is
the first such report to quantify the abundance and subcel-
lular distribution of these key elements of the Wnt canon-
ical pathway (fig. 2B).
Axin, in combination with the adenomatous polyposis coli
(APC) gene product, has been shown act as a scaffold that
chaperones β-catenin, shuttling to and from the nucleus
[23]. Axin expression in some cells and the absence of
Wnt appears to be lower than that of the other proteins in
the multiprotein complex responsible for the degradation
of β-catenin [24], but was detectable in each of the subcel-
lular (plasma membrane-, cytosol-, and nuclear-enriched)
fractions prepared from the mouse F9 cells. We estab-
lished the presence of significant amounts of Axin in all
three subcellular fractions. Approximately 35% of Axin
was associated with the plasma membrane; > 40% in
nuclear fraction; the remainder in the cytosol accounting
for < 25%.
β-catenin, in contrast, is found most abundant in the
plasma membrane-enriched fraction, likely in association
with the cell membrane-associated cadherins [25] and
Axin (fig. 2B). β-catenin was found at significant levels in
the cytosol, again perhaps in combination with its chap-
erone Axin. Nuclear fractions displayed the least content
(about 15%) of the cellular β-catenin, in the absence of
Wnt3a.
In unstimulated cells, Dishevelled-2 is found predomi-
nantly (> 80%) in the cytosol-enriched subcellular frac-
tion (fig. 2B). Approximately 10–15% of this
phosphoprotein is found associated with the plasma
membrane (fig. 2B). In the fly, Dsh (homologue of mam-
malian Dvl) has been shown to harbor both a nuclear
localization sequence (NLS) at carboxy-terminal to the
PDZ domain as well as a nuclear export signal (NES) at
the carboxy-terminal reach of the DEP domain [18].
Dishevelled-2, which does not display canonical mamma-
lian sequences for either NLS or NES, was found to be the
least abundant in the nucleus, displaying less than 3% of
the cellular complement in cells absent stimulation by
Wnt.
The serine/threonine-specific protein kinase glycogen syn-
thase kinase-3β (GSK3β) plays a pivotal role in the Wnt
canonical pathway [26], catalyzing the phosphorylation
of each of the key signaling elements under study herein.
The amount of GSK3β was found to be greatest in the
cytosol (> 50%, fig. 2B), although it was readily detected
in the plasma membrane-enriched and nuclear subcellu-
lar fractions. High levels of GSK3β activity have been
reported in the nuclei of primary cortical neurons of
mouse brain [27], although the relative abundance of this
kinase in subcellular fractions of embryonic cells has not
Table 1: Protein distribution in subcellular fractions prepared 
from mouse F9 cells. Pre-confluent F9 cells were harvested from 
P150 cultures, homogenized, and subcellular fractions prepared 
for analysis of relative protein content, as outlined in the 
Methods. The sum of these 4 subcellular fractions was set as "100 
%". The data displayed are the mean values ± S.E.M from 
separate preparations (n = 20).
Fractions Protein distribution % Protein (mg)
Nuclei 12.25 ± 0.450 01.81
Mitochondria+Microsomes 10.64 ± 0.347 01.57
Plasma Membrane 30.06 ± 1.078 04.45
Cytoplasm 47.05 ± 0.332 06.96
Total 100 14.79Journal of Molecular Signaling 2007, 2:11 http://www.jmolecularsignaling.com/content/2/1/11
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been reported. The cellular distribution of active GSK3β
and its phosphorylated, inactive form (p-GSK3β) among
the three major subcellular fractions was found to be
essentially the same in the unstimulated F9 cells.
PP2A, a serine/threonine phosphatase, implicated in the
Wnt canonical pathway [28], was found localized pre-
dominantly (> 70 %) in the cytosolic fraction. A signifi-
cant amount of this phosphoprotein phosphatase,
however, was found also in the plasma membrane-
enriched fraction. Only a small amount of PP2A (~5%)
was found in the nuclear fraction prepared from unstimu-
lated cells. Of note, the cellular distributions of PP2A and
Dvl2 in unstimulated cells appear to be quite similar, sug-
gesting the possibility of some close association between
these two key molecules. Establishing a detailed quantifi-
cation of abundance and subcellular distribution by bio-
chemical means in the unstimulated F9 cells enabled us to
proceed to an analysis of the trafficking of these key sign-
aling molecules in response to stimulation of the canoni-
cal pathway by treatment with Wnt3a.
Wnt3a stimulates a rapid trafficking of Wnt canonical 
signaling elements
Our overarching goal was to quantify the trafficking of key
signaling molecules of the Wnt/β-catenin pathway in
response to Wnt3a stimulation. Within 90 min of stimu-
lation with Wnt3a, F9 cells display a substantial increase
in the abundance of Axin, of β-catenin, and to a lesser
extent of the protein kinase GSK3β (fig. 1C). We incorpo-
rated the changes in cellular abundance, referencing the
subcellular localization established for each molecule in
the absence of Wnt (i.e., the starting time, t = 0) and quan-
tified the cellular distribution of the Axin, β-catenin, Dvl2
and GSK3β in F9 cells treated with Wnt3a (fig. 3). The
cells were stimulated with purified Wnt3a for periods up
to two hours. Immunoblots of subcellular fractions pre-
pared from large-scale growths of F9 cells treated with
Wnt3a at various times from a representative experiment
are displayed for each signaling molecule (fig. 3A). The
relative changes in distribution of the signaling molecules
among the subcellular fractions obtained from 6–10 indi-
vidual, separate experiments were compiled, analyzed sta-
tistically, and displayed (fig. 3B).
Stimulation of Wnt3a initially provokes a major recruit-
ment of Axin, β-catenin, Dvl2, and GSK3β to the plasma
membrane (fig. 3A, B). For Dvl2 and GSK3β, the transit to
the plasma membrane-enriched fraction in response to
Wnt3a is very rapid, being greatest at the earliest time
point measured, 15 min post stimulation. For Axin, a scaf-
fold for the multiprotein complex that targets β-catenin
for degradation, as well as for β-catenin itself, Wnt3a stim-
ulates a rapid increase in plasma membrane-association,
easily detected within 15 min and reaching peak values by
45 min post stimulation. The recruitment of Axin to the
plasma membrane- associated LRP5/6 co-receptor of Fz1
has been shown to be mediated by a rapid phosphoryla-
tion of LRP5/6 by CK1γ as well as by GSK3β [29,30]. Dvl2
shuttles to the plasma membrane-enriched fraction in
response to stimulation by Wnt3a, was readily observed at
15 min, attaining peak values within 30 min.
This biochemical, quantified data extend earlier results
obtained largely from immunofluoresence techniques
[31,32]. The similarity in the relative increases and tempo-
ral coincidence of the changes noted suggest that Axin,
Dvl2, and GSK3β are trafficked en masse to the plasma
membrane-enriched fraction in response to Wnt3a stimu-
lation. Unlike the response observed for Dvl2 and GSK3β,
whose abundance does not change with Wnt stimulation,
the amount of Axin and β-catenin associated with the
plasma membrane continues to increase beyond 15 min,
for nearly 60 min. Increased stabilization in response to
inhibition of the degradation complex and/or increased
synthesis of these two molecules adds substantially to the
pool of Axin and β-catenin at the plasma membrane (fig.
3B). A sustained accumulation of Axin occurs in the
cytosol in response to stimulation by Wnt3a; this accumu-
lation then accounts for much of the cellular content of
this scaffold. Trafficking of Axin to the nuclear-enriched
fraction increases to a lesser extent (two-fold) in response
to Wnt3a, transiently returning to normal within 120
min. Phosphorylation of GSK3β on Ser9 (detected by
immunoblotting with a phospho-specific antibody for p-
GSK3β) was coincident with the movement of GSK3β to
the plasma membrane, providing compelling although
indirect evidence that inactivation of GSK3β in response
to Wnt3a may occur with trafficking of this kinase to the
plasma membrane. Although Ser-9 phosphorylation has
been difficult to detect, increased phosphorylation of pep-
tides corresponding to that harboring the Ser-9 residue
has been reported in response to Wnt [33,34]. In addition,
the serine-9 to alanine mutant of GSK3β was found to be
2-fold better than the wild-type at blocking hDvl2-
induced activation of the Lef/Tcf-sensitive transcriptional
response [33]. In F9 cells, enhanced phosphorylation of
GSK3β Ser9 is observed in both the cytosol-enriched and
the plasma membrane-enriched fractions at earliest time
point measured, 15 min post stimulation by Wnt3a (fig.
3).
In the cytosol, Wnt3a stimulates a sustained 5-fold
increase in Axin as well as a more modest increase in β-cat-
enin (fig. 3B). The increase in cytosolic Axin in response
to Wnt3a follows temporally the marked and transient
increase in plasma membrane-associated Axin. For β-cat-
enin, cytosolic levels increase in response to Wnt3a, lag-
ging temporally behind sustained major increases in β-
catenin accumulation at the plasma membrane and in theJournal of Molecular Signaling 2007, 2:11 http://www.jmolecularsignaling.com/content/2/1/11
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Wnt3a stimulates a rapid shuttling of Wnt/β-catenin signaling elements Figure 3
Wnt3a stimulates a rapid shuttling of Wnt/β-catenin signaling elements. Panel A, quantified immunoblot analysis of subcellular fractions 
obtained from control cells (time = 0) and cells stimulated with purified Wnt3a. F9 cells expressing Rfz1 receptor were stimulated with Wnt3a 
for the indicated times. Cell cultures were collected, disrupted, and fractionated to the plasma membrane, cytoplasm and nuclei fractions, as 
described in Methods. Each fraction (100 μg) was subjected to SDS-PAGE and analyzed by immunoblotting with specific antibodies targeting the 
signaling molecules indicated. The three panels displayed at the bottom of the immunoblot set show blots stained with antibodies to well known 
subcellular marker proteins: Na+-K+-ATPase (plasma membrane), GAPDH (cytoplasm) and fibrillarin (nuclei), respectively. The result shown is 
representative of 10 independent experiments. Panel B, summary of the quantified trafficking of signal elements in response to Wnt3a. Bands 
were quantified by densitometry as described in Methods and values are displayed as fold of zero time point. The content of key signaling mole-
cules in the plasma membrane- (PM, blue line), cytoplasmic- (CY, pink line) and nuclear- (NU, green line) enriched subcellular fractions are dis-
played. The results are shown as mean values ± S.E. from 6–10 independent experiments.
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nucleus. Wnt3a stimulates a modest, transient increase in
cytosolic GSK3β, while cytosolic Dvl2 levels essentially
decline in response to the increased trafficking of Dvl2 to
the plasma membrane-enriched and nuclear-enriched
subcellular compartments.
With regard to shuttling to the nucleus, Wnt3a stimulates
initial 2-fold and 3-fold increases in Axin and β-catenin,
respectively (fig. 3B). The increase in nuclear Axin in
response to Wnt3a stimulation was sustained for one
hour, whereas the increase in nuclear β-catenin persisted
to 2 hr, the last time point analyzed. Axin is reported to
chaperone  β-catenin, facilitating both import to and
export from the nucleus [35-37]. Study of protein-protein
interactions in live cells using analysis such as energy
transfer may reflect the strength (i.e., distance) or tempo-
ral character of the Axin-β-catenin interaction and might
be useful in this regard (see below). Thus some portion of
the β-catenin may only be interacting with Axin as Axin
shuttles β-catenin to the nucleus, acting as a "chaperone".
GSK3β, like β-catenin, displays nuclear localization,
although a transient accumulation rather than one sus-
tained over 120 min in response to Wnt3a. Wnt3a pro-
vokes GSK3β to associate transiently in the plasma
membrane, a recruitment that peaks within 15 min of
stimulation (Fig. 3A and 3B). Wnt3a also stimulates traf-
ficking of GSK3β to the nucleus. Finally, Dvl2 shows a
modest, but sustained trafficking to the nucleus in
response to stimulation with Wnt3a. Wnt3a has been
reported to stimulate the shuttling of some Dsh to the
nucleus in Xenopus embryonic explants [18]. We demon-
strate for the first time in mammalian cells that cytoplas-
mic to nuclear shuttling of a major portion (~30%) of
Dvl2 can be observed in the mouse F9 embryonal cells
stimulated with Wnt3a (figs. 2, 3).
BRET analysis of protein-protein interactions in situ 
among key signaling molecules in the Wnt/β-catenin 
pathway
Our data suggest a close, perhaps "coupled" interaction of
Axin with Dvl2 and β-catenin during activation of the
canonical pathway by Wnt3a in mouse F9 cells (figs. 2, 3).
As early as 15 min following stimulation of the cells with
Wnt3a, we observe strikingly similar patterns of traffick-
ing of all three signaling elements to the plasma mem-
brane- and to the nuclear-enriched subcellular fractions
(fig. 3B). Not so for the results obtained by analysis of the
content of these molecules in the cytosol-enriched subcel-
lular fractions, likely reflecting the differential effects of
Wnt3a on the cellular abundance, rather than shuttling
for both Axin and β-catenin. To probe this question more
directly and in situ in live cells, we made use of biolumi-
nescence response energy transfer (BRET) in which bio-
molecular interactions can be probed in live cells [38].
The BRET partners of R-luciferase-fusion proteins and
eGFP2-fusion proteins of Axin, Dvl2, and β-catenin were
engineered and expressed in various combinations in cells
co-expressing Rfz1. Despite repeated efforts, we were not
able to express the BRET fusion proteins in F9 cells at the
levels that are necessary to provide unambiguous results
of protein-protein interaction (results not shown). As an
alternative, we employed HEK 293 cells that display a
robust synthetic and chaperone capacity for exogenously
introduced expression vectors [39]. Expression of the nec-
essary fusion protein partners was successful in the HEK
293 cells, permitting BRET2 analysis of protein-protein
interactions. BRET2  assay is performed with improved
fusion moieties (e.g., GFP2) in combination with a more
stable substrate for the Renilla luciferase (Rluc) [38,40].
Wnt3a stimulation of HEK 293 cells expressing Rfz1
resulted in robust activation of Lef/Tcf-sensitive luciferase
gene reporter (fig. 4A), similar to that observed for F9 cells
(fig. 1B). We tested the function of the fusion proteins,
exemplified by the analysis of Rfz1-Rluc, which was
shown to be fully functional (fig. 4A). The BRET ratio was
measured in live cells at 15 min following Wnt3a stimula-
tion (fig. 4B).
We detected a strong BRET2 signal from the Axin/Dvl2
partners (fig. 4B). The individual partners alone (fig. 4B)
or in combination with non-fused version of eGFP2 or R-
luciferase (controls such as Rluc/GFP2, Axin-Rluc/GFP2,
Dvl2-Rluc/GFP2, β-catenin-Rluc/GFP2, Rluc/Dvl2-GFP2,
Rluc/GSK3β-GFP2, Rluc/β-catenin etc., result not shown)
provide no significant BRET2 signal under these same con-
ditions. Protein-protein interactions of Axin with Dvl2,
Axin with GSK3β, as well as Axin with β-catenin, all gen-
erated strong BRET2 signals in the unstimulated HEK 293
cells. These BRET signals reflect the intensity (i.e., spatial
proximity) of the proteins interacting. Likewise, protein-
protein interactions probed for Dvl2 with GSK3β as well
as GSK3β with β-catenin generated substantial BRET2 sig-
nals in unstimulated cells, indicative of bona fide protein-
protein interaction between these partners.
Notable, in the cells stimulated with Wnt3a for 15 min, a
time point when Wnt-induced shuttling of these key sign-
aling elements is already well underway (fig. 3), no signif-
icant change is observed in the magnitude of the BRET2
signals for any of these protein-protein interactions (fig.
4B). Dissociation of partners or a significant decrease in
the level of protein-protein interactions in response to
Wnt3a would have been predicted to provoke a sharp
reduction or total loss of BRET2 signal. These novel data
suggest that the interactions of each protein-protein part-
ner (or interactions within a multiprotein complex that
include these partners) remain largely intact during traf-
ficking of these key signaling molecules to subcellular
fractions is response to Wnt3a (fig. 4). Either dissociation
of partners or enhanced association of these protein-pro-Journal of Molecular Signaling 2007, 2:11 http://www.jmolecularsignaling.com/content/2/1/11
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BRET2 analysis of protein-protein interactions in the Wnt/β-catenin signaling pathway Figure 4
BRET2 analysis of protein-protein interactions in the Wnt/β-catenin signaling pathway. Panel A, Lef/Tcf-sensitive gene activation in 
HEK 293 cells in response to Wnt3a. HEK 293 cells were co-transfected with either Rfz1 and M50 or Rfz1-Rluc and M50. HEK 293 cells were 
stimulated with Wnt3a (20 ng/ml) for 8 hr. Lef/Tcf-sensitive transcription activity was determined. Panel B, HEK 293 cells stably expressing Rfz1 
were transiently co-transfected with Axin-Rluc and/or Dvl2-GFP2, Dvl2-Rluc, GSK3-GFP2, β-cat-GFP2, β-cat-Rluc as indicated for 48 h and then 
treated with Wnt3a (20 ng/ml) for 15 min. BRET ratios were measured by addition of DeepBlue C (5 μM) in cells co-expressing Rluc and GFP2 
fusion proteins. Results are expressed as the mean ± S.E. of at least three independent experiments. Panel C,the β-adrenergic agonist isoprotere-
nol (Iso) stimulates the interaction between GPCR and β-arrestin2. HEK293 cells were transiently transfected with β2AR-Rluc and β-arrestin2-
GFP2 for 48 h, and then treated with Iso (10 μM) or Iso plus the β-adrenergic antagonist propranolol (Pro, 10 μM) for 0 to 60 min. Panel D, Iso 
stimulates the interaction between GPCR and the heterotrimeric G protein subunit Gβ1. HEK293 cells were transiently transfected with β2AR-
Rluc, Gβ1-GFP2, Gαs, and Gγ2 for 48 h, and then treated with agonist Iso (10 μM) or Iso plus antagonist Pro (10 μM) for 0 to 30 min. BRET ratios 
(GFP2/Rluc activity) were measured by addition of DeepBlue C (5 μM) in cells coexpressing Rluc and GFP2 fusion proteins. Results are expressed 
as the mean ± S.E. of three independent experiments. Note that isoproterenol stimulates GPCR interaction with G-protein first (peaks within 5 
min of agonist) and later leads to association of GPCR with β-arrestin2 (peaks at 30 min). Both sets of protein-protein interactions are blocked 
by simultaneous addition of propranolol with agonist.
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tein partners would have been readily detected by BRET
analysis. We tested our BRET responses using two positive
controls: the agonist-stimulated association of the β2-
adrenergic receptor with either the adaptor protein β-
arrestin2 or the G-protein β1 subunit. We assayed BRET
signals for the interaction between the β2-adrenergic
receptor-GFP2 and β-arrestin2-Rluc in response to addi-
tion of a β-adrenergic agonist in these same cells and
observed a dynamic changes in BRET signal in response to
isoproterenol (Iso, fig. 4C), an interaction that could be
blocked by simultaneous treatment with agonist and the
β-adrenergic antagonist propranolol (Pro). The lack of
change in the BRET2 signal observed in response to Wnt3a
is thus striking (fig. 4B). Similarly, using β2-adrenergic
receptor-Rluc and a trimeric Gαs that includes Gβ1-GFP2,
we readily detected increased BRET signal in response to
agonist, an interaction that could be blocked by the β-
adrenergic antagonist propranolol (fig, 4D). Note that the
observed kinetics of these two distinct protein-protein
interactions also confirm the literature, the agonist treat-
ment rapidly leads to GPCR-G protein association (within
5 min) and then later to interaction with β-arrestin2
(peaking at 30 min). Thus, using the same cells and con-
ditions we demonstrate sensitive, real time changes of
BRET signals from other GPCR signaling cascades, sup-
porting the value of such determinations for the Wnt/β-
catenin signaling cascade. At 15 min post stimulation by
Wnt3a, trafficking of Axin, Dvl2, and GSK3β is obvious,
whereas at this time the effects of Wnt3a on cellular abun-
dance of the signaling elements are not significantly
expressed. Thus, it seems likely that Axin, Dvl2, and
GSK3β operate as a relatively stable multi-protein com-
plex and that this complex shuttles to the plasma mem-
brane and to the nucleus in response to Wnt3a.
Differential localization and trafficking of Dvl1, Dvl2, and 
Dvl3 in response to Wnt3a
Unlike the fly which expresses a single Dishevelled (i.e.,
Dsh), mammalian cells can express three highly homolo-
gous isoforms of Dishevelled, termed Dvl1, Dvl2 and
Dvl3 [41]. Dvl2 is the most abundant Dvl in mouse F9
cells (results not shown). We explored the cellular distri-
bution of each mammalian Dvl expressed in F9 cells (fig.
5). All three Dvls were expressed in mouse F9 cells, as
determined by immunoblotting with isoform-specific
antibodies (fig 5A). The cellular content of Dvl1 and Dvl2
among the three subcellular fractions was nearly identical.
The bulk of Dvl1 and of Dvl2 (> 80%) is found in the
cytosol-enriched fraction, the least amount of each of
these isoforms (> 5%) is observed in the nuclear-enriched
fractions. Notable differences for the subcellular content
and distribution of Dvl3 as compare to either Dvl1 or to
Dvl2 were observed. Dvl3 content in the cytosol-enriched
fractions is markedly reduced (~30%) in comparison to
the content of either Dvl1 or Dvl2. More importantly, the
content of Dvl3 in the nuclear-enriched fraction of
unstimulated F9 cells is several folds greater than that for
either Dvl1 or Dvl2 (fig 5A).
Next we analyzed the abundance of each Dvl in cells stim-
ulated by Wnt3a (fig. 5B). As noted above (fig 1C), the
abundance of Dvl2 is unaffected by Wnt 3a stimulation.
The abundance of Dvl3 and Dvl1 following stimulation
by Wnt3a, in contrast to that of Dvl2, were increased. The
abundance of Dvl3 increases 2-fold within 5 min post-
stimulation of Wnt3a and reaches to ~2.5 fold within 15
min.
Dvl2, as shown above (fig. 3), shows a Wnt3a-stimulated
trafficking to plasma membrane- and nuclear-enriched
fractions at the expense of the cytosolic complement of
this phosphoprotein. Rapid trafficking of all three Dvls to
the plasma membrane-enriched subcellular fraction was
observed in response to stimulation by Wnt3a (fig. 5C).
The trafficking of Dvl1 and Dvl3 to the plasma membrane
and nuclear fractions in response to stimulation by
Wnt3a, unlike that of Dvl2, does not appear to occur at
the expense of cytosolic complement. Most remarkable is
the magnitude of the relative changes of Dvls for Wnt3a-
stimulated trafficking to the plasma membrane. Wnt3a
stimulates a 7-fold increase in Dvl3 trafficking to the
plasma membrane-enriched fraction, a process that con-
tinues progressively over the 120 min stimulation by
Wnt3a. The Wnt3a-stimulated increase in the abundance
of Dvl3 enables this sharp increase in accumulation at the
plasma membrane. The trafficking of Dvl1 and Dvl2 in
response to Wnt3a stimulation, in contrast, reaches a pla-
teau (3-fold and 1.3-fold, respectively) within 60 min,
thereafter declining over the next 60 min (fig. 5C).
Discussion
The Wnt canonical signaling pathway plays an essential
role in early development [2]. The input is Wnt3a which
binds to Frizzled-1, a member of the superfamily of the
heptihelical G protein-linked receptors that are embedded
in the plasma membrane [9,42]. Functional binding of
Wnt to Frizzled-1 requires the co-receptor LRP5/6, also a
plasma membrane-embedded protein [43]. Thus, signal-
ing from Wnt to the level of activation of gene transcrip-
tion in the nucleus requires additional protein(s) that can
propagate the signal physically from the inner face of the
cell membrane to the nucleus. Members of the Dsh/Dvl
family interact with the Frizzled/LRP6/Go proteins at the
membrane [44] and in combination with a multiprotein
complex are responsible for the inhibition of phosphor-
ylation of β-catenin, which targets β-catenin for degrada-
tion [9]. Dishevelled has been shown to be downstream
of Frizzled/LRP6/Go and upstream of GSK3β signaling of
both the canonical and PCP pathways in the fly, through
epistasis experiments [8,45]. It is considered that at Dsh/Journal of Molecular Signaling 2007, 2:11 http://www.jmolecularsignaling.com/content/2/1/11
Page 11 of 16
(page number not for citation purposes)
Differential effects of Wnt3a stimulation on Dvl1, Dvl2, and Dvl3 Figure 5
Differential effects of Wnt3a stimulation on Dvl1, Dvl2, and Dvl3. Panel A, the comparison of the cellular abundance of mammalian Dvl 
isoforms (Dvl1, Dvl2, and Dvl3) in subcellular fractions. F9 cells expressing Rfz1 were used to prepare subcellular fractions. Plasma membrane-
enriched (PM), cytosol-enriched (CY), and nuclear-enriched (NU) fractions were prepared as described in detail in Methods and are displayed. 
The results of multiple densitometric scans of immunoblots were quantified. The results are displayed based upon the distribution (%), the total 
protein content of the whole-cell homogenate and fractions, and quantified analysis of blots from SDS-PAGE for each molecule and various con-
trols for sample loading and blotting. The results are shown as mean values ± S.E. from 6–8 independent experiments. Panel B, the comparison of 
the cellular abundance of Dvls in response to Wnt3a. F9 cells expressing Rfz1 were stimulated with purified Wnt3a for indicated time and then 
disrupted in a lysis buffer [50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 2 mM Na3VO4, 50 mM NaF, 1 % Triton X-100, 1 mM 
phenymethysulfonyfluoride (PMSF), 10 μg/ml leupeptin, and 10 μg/ml aprotinin]. Abundance of each Dvl isoform was determined by staining of 
blots with specific antibodies against each Dvl. Fractions were also stained with anti-GAPDH antibody to establish loading equivalence. Values are 
displayed as ''fold'' of zero-time point (set to 1). A representative blot is shown and the quantification of results is shown as mean values ± S.E. 
from 6 independent experiments. Panel C, F9 cells expressing Rfz1 receptor were stimulated without or with Wnt3a. Cells were harvested at 
each time point indicated, cell lysates were fractionated into plasma membrane (PM), cytoplasm (CY) and nuclei (NU) fractions. Quantified immu-
noblotting was performed as described in Methods. Each fraction (100 μg) was subjected to SDS-PAGE and the resolved proteins analyzed by 
immunoblotting with anti-Dvl1-, anti-Dvl2- and anti-Dvl3-specific antibodies. The three panels displayed at the bottom of the immunoblot set 
show blots stained with antibodies to well known subcellular marker proteins: Na+-K+-ATPase (plasma membrane), GAPDH (cytoplasm) and 
fibrillarin (nuclei), respectively. Representative blots are shown (top panel). Summary of quantified analysis of blots from SDS-PAGE are shown 
(bottom panel). The results are shown as mean values ± S.E. from 4–6 independent experiments. Dvl1 (blue line), Dvl2 (pink line) and Dvl3 (green 
line) are displayed.Journal of Molecular Signaling 2007, 2:11 http://www.jmolecularsignaling.com/content/2/1/11
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Dvl level, Wnt signals branch to canonical, non-canonical
and PCP pathways [14].
Inhibition of GSK3β-catalyzed phosphorylation of β-cat-
enin requires the participation of members of the
dynamic multiprotein complex, including APC, Axin, and
most prominently the unique phosphoprotein Dsh/Dvl
[16,17]. APC, β-catenin and Axin have been shown capa-
ble of cycling between the cytoplasm and the nucleus [35-
37], although the extent to which these changes involve
the full cellular complement of the signaling molecules
has remained enigmatic. Elegant earlier studies were
based largely upon fluorescence and immunoblotting
techniques which indicate changes in locale, [31,32,46],
but fail to provide quantification and unambiguous tem-
poral description of shuttling to biochemically-defined
compartments of the cell. Phosphorylation plays a key
role in both changes in protein stability and localization
of these signaling elements [16,47]. In the current work
we apply well-validated biochemical techniques to ascer-
tain changes both the cellular abundance and distribution
of Axin, Dvls, β-catenin, as well as GSK3β in response to
Wnt3a. Our quest was to establish how much of the cellu-
lar content of each signaling molecule is being shuttled
and to which subcellular fraction in response to activation
of the canonical Wnt/β-catenin/Lef-Tcf-dependent tran-
scriptional pathway.
We succeed in establishing the distribution of key signal-
ing elements, defining both symmetric (for Axin, found in
all three major subcellular fractions) as well as markedly
asymmetric (for Dvl2, mostly found in the cytosol, and β-
catenin found most abundant in the plasma membrane)
distributions among plasma membrane-, cytosol-, and
nuclear-enriched subcellular fractions. Following Wnt3a
stimulation, the abundance of Axin, β-catenin and Dvl3
markedly increases, while the abundance of Dvl2 and
GSK3β was largely unaffected. The amplitude and tempo-
ral character of the shuttling of Axin, Dvl2 and GSK3β to
various well-defined subcellular fractions suggest that
these proteins may form a relatively stable complex (es)
that shuttles ultimately to the nucleus, where both Axin
and β-catenin accumulate. Recent structural insights into
Dvl and Axin suggest a role for dynamic polymerization of
Dvl via its DIX domain [48]. Our data suggests that Dvl2
and Axin form a complex that is stable in the face of
Wnt3a stimulation. Although speculation, dynamic
polymerization may be of stable complex that contain
minimally Dvl and Axin. Axin negatively regulates Wnt
canonical signaling, acting as a scaffold to which GSK3β,
β-catenin, APC, Dvl, and PP2A can be recruited.
Previous results suggested that Wnt stimulation can pro-
mote Axin degradation in mammalian cell culture [49-51]
and fly embryos [52]. We show herein a sharp increase of
abundance of Axin in response to stimulation by Wnt3a.
These earlier studies analyzed the abundance of Axin only
after 2–6 hr post stimulation by Wnt. Analysis of Axin
changes over short time courses with respect to Wnt stim-
ulation has not been reported, until now. Furthermore,
our studies were largely performed on the native signaling
molecules operating at wild-type levels of expression,
rather than with overexpressed, tagged fusion proteins
whose expression levels may well disrupt normal stoichi-
ometries and signaling.
The fly Dsh, displaying both NLS and NES, has been
shown to shuttle to the nucleus in response to activation
of the Wnt canonical pathway [18]. By high-resolution
confocal microscopy and photobleaching techniques,
others have shown that Dvl2 (and Axin) forms dynamic
"puncta" assemblies absent of cytoplasmic vesicles and
equilibrating with cytosolic pools [46]. Nuclear localiza-
tion of Dsh is required for its function in the canonical
Wnt/β-catenin signaling pathway in the fly [18,19], so
detailed analysis of the abundance and localization of
mammalian Dvls was an essential effort. Biochemical
analysis of Dvls distribution in cells stimulated with
Wnt3a enabled us to quantify temporally the accumula-
tion of Dvl1, Dvl2, and Dvl3 in the plasma membrane-
enriched and nuclear-enriched subcellular fractions. Our
results show that the bulk (> 65%) of the Dvl2 remains in
the cytosol following stimulation with Wnt3a, with about
20% transiting to the plasma membrane and > 10% of
Dvl2 accumulating over time in the nucleus in response to
Wnt3a. In contrast, the localization, changes in abun-
dance and trafficking of Dvl1, Dvl2 and Dvl3 in response
to Wnt3a are distinct.
Dvl1 and Dvl3 display increased cellular accumulation in
response to Wnt3a, Dvl2 does not. Dvl1 and Dvl3 display
Wnt3a-stimulated changes in trafficking to the plasma
membrane (2.5- and 7.0-fold, respectively), whereas, for
Dvl2, the changes are relatively small. Further analysis is
essential to elucidate how changes in the cellular abun-
dance of Dvl1 and Dvl3 impact Wnt/β-catenin signaling.
Our biochemical data demonstrate Wnt-stimulated traf-
ficking of Dvl isoforms to the nucleus in mammalian
cells, similar to nuclear localization of Dsh observed in
the fly [18]. Nuclear accumulation of Dvl2 was minimal,
whereas nuclear accumulation of Dvl1 was transient, and
that of Dvl3 was prominent (~3-fold) in response to stim-
ulation with Wnt3a. Unique differences in cellular distri-
bution of the three Dvls as well as their nuclear
localization in response to Wnt3a suggest the possible
existence of isoform-specific roles of the highly homolo-
gous mammalian Dvl1, Dvl2, and Dvl3 in Wnt/β-catenin
signaling pathway.Journal of Molecular Signaling 2007, 2:11 http://www.jmolecularsignaling.com/content/2/1/11
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Analysis of the bimolecular protein-protein interactions
in live cells using BRET technology demonstrates strong
protein-protein interactions between Axin and Dvl2,
between Axin and GSK3β, and between Dvl2 and GSK3β.
The cellular localization/trafficking of the partners in
these multiprotein complexes is shown biochemically to
be regulated by stimulation with Wnt3a. The BRET2-
derived protein-protein signals from these partner interac-
tions, however, remained essentially unchanged in
response to stimulation of the cells with Wnt3a, although
Wnt3a-stimulated trafficking among subcellular fractions
was obvious.
Conclusion
This study provides a detailed biochemical analysis of sig-
naling elements key to Wnt3a regulation of the canonical
pathway. Based upon these biochemical determinations,
we speculate that Wnt3a action does not catalyze dramatic
changes in the composition of the signaling complexes
that include these key signaling molecules. Rather, Wnt3a
acts to traffic these relatively stable complexes from one
cellular local to another, as evidenced by changes in the
content of these molecules in well-defined subcellular
fractions prepared from Wnt3a-responsive cells (F9 and
HEK 293 cells alike). With the detailed characterization of
these effects of Wnt3a on trafficking of Axin, Dvls, GSK3β
and β-catenin in mammalian cells in cultures, the bio-
chemical basis for how Wnt3a regulates the trafficking of
these molecules during the activation of the canonical
pathway becomes addressable.
Methods
Materials
The following reagents were purchased from the indicated
commercial supplier(s): anti-Dvl1, Dvl2 and Dvl3 anti-
bodies from Santa Cruz Biotechnology (Santa Cruz, CA);
anti-GSK3β antibody from Cell Signaling (Danvers, MA);
anti-Axin, anti-protein phosphatase 2A (PP2A) C subunit,
and anti-phosphoserine-9-GSK3β antibodies from
Upstate Biotechnology (Lake Placid, NY); anti-β-catenin
antibody from Sigma (St. Louis, MO); anti-glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), anti-Na+-
K+-ATPase, and anti-fibrillarin antibodies from Abcam
(Cambridge, MA); anti-cytokeratin endoA antibody
TROMA-1 from the University of Iowa Developmental
Studies Hybridoma Bank (Iowa City, IA), Immobilon
membrane from Millipore (Bedford, MA) ;and, purified,
biologically active Wnt3a and anti-Axin antibody from R&
D Systems (Minneapolis, MN). All BRET parent vectors
including pGFP2-N1, N2, N3, C1, C2, or C3 and pRluc-
N1, N2, N3, C1, C2, or C3 were purchased from BioSignal
Packard (Montreal, Canada).
Cell culture and transfection
The mouse F9 teratocarcinoma cells (F9) and human
embryonic kidney 293 (HEK) cells were obtained from
ATCC collection (Manassas, VA) and grown in Dulbecco's
modified Eagle's medium (DMEM) supplemented with
15 % fetal bovine serum and penicillin/streptomycin at
37°C in 5 % CO2. Cells were transfected transiently with
an expression vector (pCDNA3) harboring the rat Friz-
zled-1 (Rfz1) using lipofectamin (Invitrogen, Carisbad,
CA) according to the commercial instructions. Cells were
stimulated with purified Wnt3a at a final concentration of
20 ng/ml.
Formation of primitive endoderm (PE)
Mouse F9 cells were transiently transfected to express Rfz1
(above) and then stimulated with purified Wnt3a for
three days. Cells were cultured in DMEM medium for two
more days and then were lysed in a RIPA buffer [50 mM
Tris-HCl, pH 7.2, 150 mM NaCl, 5 mM EDTA, 2 mM
Na3VO4, 1% NP-40, 0.25 % sodium deoxycholate and
0.05 % SDS, 1 mM phenymethysulfonyfluoride (PMSF),
10 μg/ml leupeptin, and 10 μg/ml aprotinin]. Cell extracts
were analyzed for expression of the primitive endoderm-
marker protein cytokeratin endoA by immunoblotting
and staining with the anti-endoA, TROMA-1 monoclonal
antibody.
Lef/Tcf-sensitive transcriptional reporter gene assay
F9 cells were grown on 12-well plates and co-transfected
with Rfz1 and either Super8xTOPFlash (M50) or the con-
trol plasmid harboring a β-catenin-insensitive promoter,
Super8xFOPFlash (M51) [53]. After 1–2 days transfection,
cells were treated with Wnt3a for up to 8 hr and then har-
vested and washed with phosphate-buffered saline (PBS)
two times. Cells were harvested and lysed in a reporter
gene lysis buffer [12.5 mM Tris-H3PO4 pH 7.8, 1 mM
trans-1, 2-cyclohexanediaminetetraacetic acid (CDTA), 2
mM DTT, 10% glycerol and 1 % Triton X-100 (Promega,
Madison, WI)]. Cell extracts were assayed for luciferase
activity according to the manufacture's instructions (Strat-
agene, La Jolla, CA). Luciferase activity was normalized to
the protein concentration of the cell lysates.
Disruption & subcellular fractionation of cells
Cells propagated in P150 Petri dishes for optimal growth
were either untreated or stimulated with purified Wnt3a
for the times indicated in the figure legends. Cells were
washed with PBS twice and harvested. Cells underwent
disruption and subcellular fractionation as described pre-
viously [54]. Briefly, cells suspended in ice-cold buffer A
(10 mM Hepes, pH 7.0, 5 mM MgCl2, 25 mM KCl, 1 mM
Na3VO4, 1 mM PMSF, 10 μg/ml leupeptin, and 10 μg/ml
aprotinin) were disrupted by repeated passage (10-times)
through a 23-gauge needle and then mixed immediately
with an equal volume of ice-cold buffer A containing ofJournal of Molecular Signaling 2007, 2:11 http://www.jmolecularsignaling.com/content/2/1/11
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0.25 M sucrose. Nuclei and unbroken cells were collected
by centrifugation at 500 × g for 10 min. These cell pellets
were resuspended again in an equal volume of ice-cold
buffer A containing 0.1 % of NP-40 and then homoge-
nized again by passage through a 23-gauge needle ten
times. Nuclei were isolated by centrifugation at 500 × g for
10 min, washed once with buffer A containing of 0.1 % of
NP-40, and lysed in a lysis buffer (10 mM Hepes, pH 7.0,
0.5 M KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM DTT, 1
mM PMSF, 10 μg/ml leupeptin, and 10 μg/ml aprotinin).
The subcellular fractions enriched in nuclei (NU) were
prepared by centrifugation. After nuclei and unbroken cell
were removed by centrifugation, EDTA was added to a
final concentration of 10 mM and the mixture subjected
to centrifugation at 16,000 × g for 15 min. The resultant
pellets were washed once with buffer A containing of 0.25
M sucrose and lysed in a RIPA buffer (50 mM Tris-HCl, pH
7.2, 150 mM NaCl, 5 mM EDTA, 2 mM Na3VO4, 1% NP-
40, 0.25 % sodium deoxycholate and 0.05 % SDS, 1 mM
PMSF, 10 μg/ml leupeptin, and 10 μg/ml aprotinin).
These fractions represent the standard subcellular frac-
tions enriched in mitochondria + microsomes (M&M).
The supernatant fractions then were centrifuged at
100,000 × g for 1 hr. The 100,000 × g supernatants repre-
sent the standard subcellular fraction enriched in cytosol
(CY). The 100,000 × g pellets were washed with buffer A
containing of 0.25 M sucrose once and lysed in a buffer
(10 mM Tris-HCl, pH 7.5, 5 mM EDTA, 150 mM NaCl, 2
mM Na3VO4, 0.5 % NP-40 and 1 % Triton). This fraction
represents the standard subcellular fraction enriched in
plasma membrane (PM). A sample (5%) of the whole-cell
suspension typically was lysed directly in RIPA buffer for
determinations of total cellular protein content, of quan-
tification of marker proteins, and of protein yields.
Protein content was determined by use of the Bradford
assay. The purity of these enriched subcellular fractions
was established by subjecting aliquots of each fraction to
SDS-PAGE and the resolved proteins to immunoblotting.
The immunoblots were stained with antibodies against
each of the following protein markers employed routinely
to establish the relative purity of subcellular fractions:
anti-Na+-K+- ATPase (for plasma membrane), anti-
GAPDH (for cytoplasm), and anti-fibrillarin (for
nucleus).
Immunoblotting
Proteins (30–100 μg protein/lane) were analyzed rou-
tinely on 8 % SDS-polyacrylamide gels (polymerized
overnight) and the resolved proteins were transferred elec-
trophoretically to Immobilon membrane "blots". The
blots were stained with the antibodies indicated in the fig-
ure legends. Immune complexes were made visible using
a horseradish peroxidase-conjugated, secondary antibody
in tandem with ECL chemiluminescence. For Axin analy-
sis, two distinct epitope antibodies were applied. Phospo-
rylation (Ser-9) of GSK3β was used as physiological
indicator of GSK3β.
Quantification of stained proteins on immunoblots
Exposed films were scanned by calibrated Umax 1000
absorbance scanner equipped with SilverFastAi software
(LaserSoft Imaging Inc. Longboat Key, FL). The bands
were quantified by use of Aida software (Raytest, Ger-
many).
Analysis of protein-protein interactions by BRET
For routine BRET2 measurements, cells were washed once
with PBS, detached with 5 mM EDTA in PBS, and resus-
pended in BRET assay buffer (1× PBS buffer, plus 0.1%
glucose) 48 h after transfection, as previously described
[38]. The cells were treated with Wnt3a (20 ng/ml) for 15
min and readings of Renilla luciferase and GFP2 activity
were then collected using a multidetector plate reader
Mithras LB940 (Berthold Technologies, Oak Ridge, TN)
after addition of assay substrate, Deep Blue coelenterazine
(DeepBlueC, BioSignal Packard, Meriden, CT). Emission
filters with 400 nm and 515 nm were used to detect
Renilla luciferase (Rluc) and green fluorescence protein 2
(GFP2) activities, respectively. The BRET signal was deter-
mined by calculating the ratio of the light emitted by
GFP2-fusion protein (515 nm) over the light emitted by
Rluc-fusion protein (400 nm). The background signal was
determined in cells in which an Rluc construct alone was
expressed. The XhoI and HindIII cloning sites of pRluc-N3
were employed for creation of Rluc fusion proteins of
interest. Dvl2-GFP2 constructs were prepared by cloning
mouse Dvl2 cDNA into the HindIII-BamHI site of pGFP2-
N2, respectively. GSK3-GFP2 was constructed by cloning
human GSK3β cDNA into the EcoRI-ApaI site of pGFP-C3.
All of above constructs were created with haemagglutin
(HA) tags on their N- termini. β-catenin-Rluc and β-cat-
enin-GFP2 were constructed by ligating the human β-cat-
enin cDNA into the KpnI-BamHI  site of pRluc-N1 and
pGFP2-N1, respectively. Axin-Rluc was prepared by clon-
ing the mouse Axin I cDNA into the MluI-SacII site of
pRluc-N3 vector. The sequence of all constructs was con-
firmed by DNA sequencing.
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SDS-PAGE: Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Author's contributions
NY designed the study, analyzed the data and drafted the
manuscript. DY carried out the BRET analysis and luci-
ferase assay in HEK 293 cells. CCM participated in coordi-
nation and helped to draft the manuscript. All authors
read and approved the final manuscript.
Acknowledgements
We thank members of the laboratory for careful discussions and critical 
review of the manuscript.
References
1. Wang J, Wynshaw-Boris A: The canonical Wnt pathway in early
mammalian embryogenesis and stem cell maintenance/dif-
ferentiation.  Curr Opin Genet Dev 2004, 14:533-539.
2. Cadigan KM, Nusse R: Wnt signaling: a common theme in ani-
mal development.  Genes Dev 1997, 11:3286-3305.
3. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya
T, Yates JR, Nusse R 3rd: Wnt proteins are lipid-modified and
can act as stem cell growth factors.  Nature 2003, 423:448-452.
4. Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP, Andrew
D, Nathans J, Nusse R: A new member of the frizzled family
from Drosophila functions as a Wingless receptor.  Nature
1996, 382:225-230.
5. Yang-Snyder J, Miller JR, Brown JD, Lai CJ, Moon RT: A frizzled
homolog functions in a vertebrate Wnt signaling pathway.
Curr Biol 1996, 6:1302-1306.
6. Liu T, DeCostanzo AJ, Liu X, Wang H, Hallagan S, Moon RT, Malbon
CC: G protein signaling from activated rat frizzled-1 to the
beta-catenin-Lef-Tcf pathway.  Science 2001, 292:1718-1722.
7. Wang HY, Malbon CC: Wnt-frizzled signaling to G-protein-
coupled effectors.  Cell Mol Life Sci 2004, 61:69-75.
8. Katanaev VL, Ponzielli R, Semeriva M, Tomlinson A: Trimeric G
protein-dependent frizzled signaling in Drosophila.  Cell 2005,
120:111-122.
9. Malbon CC: G proteins in development.  Nat Rev Mol Cell Biol
2005, 6:689-701.
10. Clevers H: Wnt/beta-catenin signaling in development and
disease.  Cell 2006, 127:469-480.
11. Glass DA 2nd, Karsenty G: Molecular bases of the regulation of
bone remodeling by the canonical Wnt signaling pathway.
Curr Top Dev Biol 2006, 73:43-84.
12. Yanagawa S, van Leeuwen F, Wodarz A, Klingensmith J, Nusse R: The
dishevelled protein is modified by wingless signaling in Dro-
sophila.  Genes Dev 1995, 9:1087-1097.
13. Wharton KA Jr: Runnin' with the Dvl: proteins that associate
with Dsh/Dvl and their significance to Wnt signal transduc-
tion.  Dev Biol 2003, 253:1-17.
14. Wallingford JB, Habas R: The developmental biology of Dishev-
elled: an enigmatic protein governing cell fate and cell polar-
ity.  Development 2005, 132:4421-4436.
15. Nusse R: WNT targets. Repression and activation.  Trends
Genet 1999, 15:1-3.
16. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P: Down-
regulation of beta-catenin by human Axin and its association
with the APC tumor suppressor, beta-catenin and GSK3
beta.  Curr Biol 1998, 8:573-581.
17. Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S,
Kikuchi A: Axin, a negative regulator of the wnt signaling
pathway, directly interacts with adenomatous polyposis coli
and regulates the stabilization of beta-catenin.  J Biol Chem
1998, 273:10823-10826.
18. Itoh K, Brott BK, Bae GU, Ratcliffe MJ, Sokol SY: Nuclear localiza-
tion is required for Dishevelled function in Wnt/beta-catenin
signaling.  J Biol 2005, 4:3.
19. Habas R, Dawid IB: Dishevelled and Wnt signaling: is the
nucleus the final frontier?  J Biol 2005, 4:2.
20. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler
KW, Vogelstein B, Clevers H: Constitutive transcriptional acti-
vation by a beta-catenin-Tcf complex in APC-/- colon carci-
noma.  Science 1997, 275:1784-1787.
21. Seto ES, Bellen HJ: The ins and outs of Wingless signaling.
Trends Cell Biol 2004, 14:45-53.
22. DePierre JW, Karnovsky ML: Plasma membranes of mamma-
lian cells: a review of methods for their characterization and
isolation.  J Cell Biol 1973, 56:275-303.
23. Luo W, Lin SC: Axin: a master scaffold for multiple signaling
pathways.  Neurosignals 2004, 13:99-113.
24. Lee E, Salic A, Kruger R, Heinrich R, Kirschner MW: The roles of
APC and Axin derived from experimental and theoretical
analysis of the Wnt pathway.  PLoS Biol 2003, 1:E10.
25. Nelson WJ, Nusse R: Convergence of Wnt, beta-catenin, and
cadherin pathways.  Science 2004, 303:1483-1487.
26. Cadigan KM, Liu YI: Wnt signaling: complexity at the surface.  J
Cell Sci 2006, 119:395-402.
27. Bijur GN, Jope RS: Glycogen synthase kinase-3 beta is highly
activated in nuclei and mitochondria.  Neuroreport 2003,
14:2415-2419.
28. Ratcliffe MJ, Itoh K, Sokol SY: A positive role for the PP2A cata-
lytic subunit in Wnt signal transduction.  J Biol Chem 2000,
275:35680-35683.
29. Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R, Okamura H,
Woodgett J, He X: A dual-kinase mechanism for Wnt co-
receptor phosphorylation and activation.  Nature 2005,
438:873-877.
30. Davidson G, Wu W, Shen J, Bilic J, Fenger U, Stannek P, Glinka A, Nie-
hrs C: Casein kinase 1 gamma couples Wnt receptor activa-
tion to cytoplasmic signal transduction.  Nature 2005,
438:867-872.
31. Endo Y, Wolf V, Muraiso K, Kamijo K, Soon L, Uren A, Barshishat-
Kupper M, Rubin JS: Wnt-3a-dependent cell motility involves
RhoA activation and is specifically regulated by dishevelled-
2.  J Biol Chem 2005, 280:777-786.
32. Torres MA, Nelson WJ: Colocalization and redistribution of
dishevelled and actin during Wnt-induced mesenchymal
morphogenesis.  J Cell Biol 2000, 149:1433-1442.
33. Ding VW, Chen RH, McCormick F: Differential regulation of gly-
cogen synthase kinase 3beta by insulin and Wnt signaling.  J
Biol Chem 2000, 275:32475-32481.
34. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez
R, Alessi DR: Role that phosphorylation of GSK3 plays in insu-
lin and Wnt signalling efined by knockin analysis.  Embo J 2005,
24:1571-1583.
35. Bienz M: The subcellular destinations of APC proteins.  Nat Rev
Mol Cell Biol 2002, 3:328-338.
36. Henderson BR, Fagotto F: The ins and outs of APC and beta-cat-
enin nuclear transport.  EMBO Rep 2002, 3:834-839.
37. Wiechens N, Heinle K, Englmeier L, Schohl A, Fagotto F: Nucleo-
cytoplasmic shuttling of Axin, a negative regulator of the
Wnt-beta-catenin Pathway.  J Biol Chem 2004, 279:5263-5267.
38. Mercier JF, Salahpour A, Angers S, Breit A, Bouvier M: Quantitative
assessment of beta 1- and beta 2-adrenergic receptor homo-
and heterodimerization by bioluminescence resonance
energy transfer.  J Biol Chem 2002, 277:44925-44931.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Molecular Signaling 2007, 2:11 http://www.jmolecularsignaling.com/content/2/1/11
Page 16 of 16
(page number not for citation purposes)
39. Thomas P, Smart TG: HEK293 cell line: a vehicle for the expres-
sion of recombinant proteins.  J Pharmacol Toxicol Methods 2005,
51:187-200.
40. Bertrand L, Parent S, Caron M, Legault M, Joly E, Angers S, Bouvier
M, Brown M, Houle B, Menard L: The BRET2/arrestin assay in
stable recombinant cells: a platform to screen for com-
pounds that interact with G protein-coupled receptors
(GPCRS).  J Recept Signal Transduct Res 2002, 22:533-541.
41. Malbon CC, Wang HY: Dishevelled: a mobile scaffold catalyzing
development.  Curr Top Dev Biol 2006, 72:153-166.
42. Morris AJ, Malbon CC: Physiological regulation of G protein-
linked signaling.  Physiol Rev 1999, 79:1373-1430.
43. He X, Semenov M, Tamai K, Zeng X: LDL receptor-related pro-
teins 5 and 6 in Wnt/beta-catenin signaling: arrows point the
way.  Development 2004, 131:1663-1677.
44. Wnt Homepage   [http://www.stanford.edu/~rnusse/wntwin
dow.html]
45. Katanaev VL, Tomlinson A: Multiple Roles of a Trimeric G Pro-
tein in Drosophila Cell Polarization.  Cell Cycle 2006,
5:2464-2472.
46. Schwarz-Romond T, Merrifield C, Nichols BJ, Bienz M: The Wnt sig-
nalling effector Dishevelled forms dynamic protein assem-
blies rather than stable associations with cytoplasmic
vesicles.  J Cell Sci 2005, 118:5269-5277.
47. Kikuchi A, Kishida S, Yamamoto H: Regulation of Wnt signaling
by protein-protein interaction and post-translational modifi-
cations.  Exp Mol Med 2006, 38:1-10.
48. Schwarz-Romond T, Fiedler M, Shibata N, Butler PJ, Kikuchi A,
Higuchi Y, Bienz M: The DIX domain of Dishevelled confers
Wnt signaling by dynamic polymerization.  Nat Struct Mol Biol
2007, 14:484-492.
49. Willert K, Shibamoto S, Nusse R: Wnt-induced dephosphoryla-
tion of axin releases beta-catenin from the axin complex.
Genes Dev 1999, 13:1768-1773.
50. Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A:
Phosphorylation of axin, a Wnt signal negative regulator, by
glycogen synthase kinase-3beta regulates its stability.  J Biol
Chem 1999, 274:10681-10684.
51. Mao J, Wang J, Liu B, Pan W, Farr GH 3rd, Flynn C, Yuan H, Takada
S, Kimelman D, Li L, Wu D: Low-density lipoprotein receptor-
related protein-5 binds to Axin and regulates the canonical
Wnt signaling pathway.  Mol Cell 2001, 7:801-809.
52. Tolwinski NS, Wehrli M, Rives A, Erdeniz N, DiNardo S, Wieschaus
E: Wg/Wnt signal can be transmitted through arrow/LRP5, 6
and Axin independently of Zw3/Gsk3beta activity.  Dev Cell
2003, 4:407-418.
53. Seto ES, Bellen HJ: Internalization is required for proper Wing-
less signaling in Drosophila melanogaster.  J Cell Biol 2006,
173:95-106.
54. Yokoyama N, Reich NC, Miller WT: Involvement of protein
phosphatase 2A in the interleukin-3-stimulated Jak2-Stat5
signaling pathway.  J Interferon Cytokine Res 2001, 21:369-378.